Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain.
Vaccine
; 21(7-8): 725-8, 2003 Jan 30.
Article
en En
| MEDLINE
| ID: mdl-12531349
ABSTRACT
During the fourth quarter of 1997, a vaccination campaign using the meningococcal C polysaccharide vaccine was carried out in 14 autonomous regions of Spain. The remaining three regions did not participate. In the last quarter of the year 2000, a mass vaccination campaign using the meningococcal C conjugated vaccine was carried out in all regions. In the year 2001 the incidence decreased in all regions, although the decrease was greater in regions that did not vaccinate in 1997. In contrast, case fatality rates did not decrease. During 2001, the incidence rate of meningococcal C disease was still lower (0.32 per 100000 persons-year) in the regions that vaccinated in 1997 with the polysaccharide vaccine than in those that did not (0.64 per 100000 persons-year).
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Polisacáridos
/
Vacunación Masiva
/
Vacunas Meningococicas
/
Neisseria meningitidis Serogrupo C
/
Meningitis Meningocócica
Tipo de estudio:
Screening_studies
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Infant
País/Región como asunto:
Europa
Idioma:
En
Revista:
Vaccine
Año:
2003
Tipo del documento:
Article
País de afiliación:
España